Anesthesia Technique and Postoperative Sleep Quality After Septoplasty

April 21, 2026 updated by: Sevim Şenol Karataş

Evaluation of the Relationship Between Anesthesia Type and Postoperative Sleep Quality in Patients Undergoing Septoplasty: A Prospective Observational Study

This prospective observational study aims to evaluate the relationship between anesthesia type and postoperative sleep quality in adult patients undergoing septoplasty. Patients will receive either total intravenous anesthesia or inhalational anesthesia as part of routine clinical care, without any intervention or modification to standard practice. Postoperative sleep quality will be assessed using the Richards-Campbell Sleep Questionnaire on postoperative days 7 and 15 through structured telephone interviews. Secondary outcomes include postoperative pain intensity, opioid consumption, and postoperative nausea and vomiting. The study seeks to provide real-world evidence on the association between anesthetic approach and posto

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

72

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Elaziğ
      • Elâzığ, Elaziğ, Turkey (Türkiye)
        • Fethi Sekin City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of adult patients aged 18 years and older who undergo elective septoplasty at Elazig Fethi Sekin City Hospital. Eligible participants are classified as American Society of Anesthesiologists (ASA) physical status I-III and receive either total intravenous anesthesia or inhalational anesthesia as part of routine clinical care. Patients are enrolled consecutively after providing written informed consent, and no intervention or modification to standard anesthetic or postoperative management is performed as part of the study.

Description

Inclusion Criteria:

  • • American Society of Anesthesiologists (ASA) Class I-III

    • Patients aged 18 and over
    • Those who provided written informed consent at the preoperative anesthesia clinic and allowed telephone follow-up on days 2/8.

Exclusion Criteria:

  • • ASA Class IV and V

    • Patients under 18 years of age
    • Treatment of severe sleep disorders: Those with severe OSA confirmed by polysomnography and using active CPAP therapy. • Significant cognitive impairment, delirium, active psychotic disorder that prevents reliable completion of scales. • Regular use of hypnotics/benzodiazepines, sedatives/antipsychotics, or chronic opioids (≥3 days/week in the last month), alcohol or substance abuse. • Perioperative complications: Major complications during surgery, unplanned need for intensive care, or reoperation within the first 24 hours. • Pregnancy or breastfeeding. • Severe systemic disease, unstable cardiopulmonary status.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Total Intravenous Anesthesia (TIVA)
Inhalational Anesthesia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Richards-Campbell Sleep Questionnaire (RCSQ) Total Score
Time Frame: Postoperative day 7 and postoperative day 15
Postoperative sleep quality will be assessed using the Richards-Campbell Sleep Questionnaire. The total RCSQ score is calculated as the mean of five items scored on a 0-100 visual analog scale, with higher scores indicating better sleep quality.
Postoperative day 7 and postoperative day 15

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sevim Şenol Karataş

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2025

Primary Completion (Actual)

March 10, 2026

Study Completion (Actual)

March 15, 2026

Study Registration Dates

First Submitted

February 11, 2026

First Submitted That Met QC Criteria

February 11, 2026

First Posted (Actual)

February 18, 2026

Study Record Updates

Last Update Posted (Actual)

April 24, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • SEPTUM-ANESTH-SLEEP-2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Sleep Quality

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe